Why the study?
Does enteric-coated aspirin prevent gastric mucosal injury compared to buffered aspirin?
Does enteric-coated aspirin prevent gastric mucosal injury compared to buffered aspirin?
For long-term use, enteric-coated aspirin may provide a safer alternative to buffered aspirin regarding gastric mucosal injury.
Answers are grounded in this paper and cite their sources.
May warrant preference for enteric-coated aspirin in chronic users at gastric risk; leaves open prospective confirmation.
OBJECTIVE: To evaluate through clinical trials the risk of various aspirin preparations on the gastric mucosa. DATA SOURCES: Articles reporting clinical research were accessed through MEDLINE (1980-November 1998). Key search terms included enteric-coated aspirin, buffered aspirin, and gastrointestinal (GI) bleeding. DATA SYNTHESIS: Aspirin products are known to cause GI bleeding. Enteric-coated aspirin may provide an additional protective effect on gastric mucosa compared with buffered aspirin. An evaluation of studies comparing various aspirin preparations and the risk of gastric mucosal injury was conducted. CONCLUSIONS: For long-term use, enteric-coated aspirin may provide a safer alternative than buffered aspirin; however, further studies are necessary.
No takes yet. Share an insight, caveat, or question.
Banoob et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: